Recent posts

TypePostAuthorRepliesLast updated
Blog entryIndia Patent Office denies patent for prostate cancer drug sold under brand name Xtandi, generic name enzalutamide James Love019 weeks 4 days ago
Blog entry9 November 2016 - WTO TRIPS Council - WHO's intervention on the Report of the UN High-Level Panel on Access to Medicines thiru019 weeks 5 days ago
Blog entry9 November 2016 - WTO TRIPS Council - India's intervention on the Report of the UN High-Level Panel on Access to Medicines thiru019 weeks 5 days ago
Blog entry9 November 2016 - WTO TRIPS Council - Brazil's intervention on the Report of the UN High-Level Panel on Access to Medicines thiru019 weeks 5 days ago
Blog entryLancet Commission on Essential Medicines Policies publishes 74 page report, endorses delinkage of R&D costs from drug prices James Love019 weeks 6 days ago
Blog entryWHO to Colombia Minister of Health: Unaffordable drug prices are a legitimate reason for issuing a compulsory license Andrew Goldman020 weeks 20 hours ago
Blog entrySome measures that a new President and/or Congress can take to lower drug prices in the near term James Love020 weeks 5 days ago
Blog entryWTO TRIPS Council - Brazil, China, India and South Africa request discussion of the UN High-Level Panel on Access to Medicines Staff021 weeks 31 min ago
Blog entryHIV revenues and industry investments in clinical trials for HIV James Love021 weeks 12 hours ago
Blog entryRelative prices of brand and generic drugs James Love021 weeks 17 hours ago
Blog entryWashington Monthly Cover Story Highlights Petition to Lower Price of Xtandi in U.S. KEI Staff021 weeks 3 days ago
Blog entryExtending Bayh-Dole March-in rights James Love021 weeks 4 days ago
Blog entryFace time is policy: Appointment logs for USTR officials Froman, Holleyman and Punke, through July 2016 James Love021 weeks 5 days ago
Blog entry56 NGOs ask US Government enable export of low cost generic versions Xtandi to developing countries Zack Struver022 weeks 16 hours ago
Blog entryKite Pharma Press Releases & News Stories Related to Relationship with National Cancer Institute Zack Struver022 weeks 4 days ago
Page2016: KEI comments on NIH proposal for exclusive licenses to Dedalus Pharma, LLC Diane Singhroy022 weeks 4 days ago
Blog entry17 October 2016: USTR Ambassador Michael Froman's reflections on the United Nations High-Level Panel on Access to Medicines thiru022 weeks 5 days ago
Blog entryKite Pharma Uses CRADAs to Conduct Important Clinical Research on New Cancer Treatments Zack Struver022 weeks 6 days ago
Blog entry5 October 2016: Statement of Knowledge Ecology International at inaugural Marrakesh Treaty Assembly thiru024 weeks 3 days ago
Blog entryWIPO GA 2016: Statement by India on behalf of Asia Pacific Group - Report on the IGC thiru024 weeks 4 days ago
Blog entryWIPO General Assembly 2016: Statement of Knowledge Ecology International on the Report of the SCCR thiru024 weeks 6 days ago
Blog entryWIPO General Assembly 2016: Opening Statement of Knowledge Ecology International KEI Staff024 weeks 6 days ago
Blog entryGeneral Assembly 2016 - Opening Statement of Bangladesh on behalf of the LDC Group thiru025 weeks 7 hours ago
Blog entryDeciphering consultant speak: Romulus, a case study thiru025 weeks 21 hours ago
Blog entryWIPO General Assembly 2016: Opening statement of Chile on behalf of the Group of Latin and the Caribbean Group (GRULAC) thiru025 weeks 1 day ago